This inventor holds 1 USPTO granted patent. Top assignee: Hammi Holdings Co., Ltd. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Yoon Ju Lee: Innovator in Pharmaceutical Chemistry
Introduction
Yoon Ju Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of important compounds used in cancer treatment.
Latest Patents
Yoon Ju Lee holds a patent for "Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein." This invention relates to a method for efficiently preparing capecitabine, a vital drug in cancer therapy. The method utilizes a beta-anomer-rich trialkyl carbonate compound as an intermediate, allowing for the production of highly pure capecitabine with a high yield.
Career Highlights
Yoon Ju Lee is associated with Hammi Holdings Co., Ltd., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing methods that enhance the efficiency and purity of drug compounds.
Collaborations
He collaborates with notable colleagues, including Jaeheon Lee and Gha-Seung Park, contributing to innovative projects within the company.
Conclusion
Yoon Ju Lee's contributions to pharmaceutical chemistry, particularly through his patent on capecitabine preparation, highlight his role as an influential inventor in the field. His work continues to impact cancer treatment methodologies positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile